Tzu-Rong Peng

32PUBLICATIONS
5CO-AUTHORS
Metabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMolecular targetsObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 11, 2026
Clinical evidence of semaglutide for metabolic dysfunction-associated steatotic liver disease (MASLD): An updated meta-analysis.

|May 04, 2026
Revisiting the Role of Lorazepam as an Adjunct in the Management of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis.

|Feb 27, 2026
Inconsistency in the Association Between Proton Pump Inhibitor Use and Dementia Risk: An Updated Meta-Analysis.

Tzu-Rong Peng, Hung-Hong Lin, Li-Jou Yang

|Feb 17, 2026
Comparative efficacy of immune checkpoint inhibitor-based regimens versus tyrosine kinase inhibitors in advanced hepatocellular carcinoma stratified by etiology: a systematic review and meta-analysis.

Tzu-Rong Peng, Yun-Hui Huang, Ta-Wei Wu

|Jul 21, 2025
Exploring the Efficacy and Safety of Tirzepatide in Obesity Management and Cardiometabolic Risk Factors: A Comprehensive Systematic Review and Meta-Analysis.

Jian-Ying Wang, Jyun-Wei Kang, Tzu-Rong Peng

|Jul 21, 2025
Raloxifene as an Adjuvant Therapy for Patients With Schizophrenia: An Up-To-Date Systematic Review and Meta-Analysis.

Tzu-Rong Peng, Hung-Hong Lin, Jian-Ying Wang

Pageof 6

Frequent Collaborators

2 joint publications

Ching-Sheng Hsu

1 joint publications

Boon-Kok Ng

1 joint publications

Jian-Ying Wang

1 joint publications

Ming-Chia Lee